Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 13/20 | 0.39 |
| ▸ | MME | P08473 | 12/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840844 | 0.92 | AGTR1 (0.41) | AGTR1MME | |
| SCHEMBL840456 | 0.92 | AGTR1 (0.41) | AGTR1MME | |
| SCHEMBL841048 | 0.91 | HDAC1 (0.40) | AGTR1MMEALDH1A1 | |
| SCHEMBL839522 | 0.91 | AGTR1 (0.38) | AGTR1MME | |
| SCHEMBL840597 | 0.90 | AGTR1 (0.43) | AGTR1MME | |
| SCHEMBL841053 | 0.90 | REN (0.42) | AGTR1MME | |
| SCHEMBL839870 | 0.90 | AGTR1 (0.40) | AGTR1MME | |
| SCHEMBL841279 | 0.89 | AGTR1 (0.42) | AGTR1MME | |
| SCHEMBL840470 | 0.89 | LTB4R2 (0.43) | AGTR1MMEMMP8GAA | |
| SCHEMBL841138 | 0.89 | AGTR1 (0.42) | AGTR1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143298-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2012-03-27 | — | — | US | disclosed |